Interstitial pneumonitis associated with bleomycin therapy.
D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D001707:Biopsy, Needle; D001761:Bleomycin / Q000009:adverse effects; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy; D006801:Humans; D008168:Lung / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010307:Parotid Neoplasms / Q000188:drug therapy; D011650:Pulmonary Alveoli / Q000473:pathology; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000473:pathology; D012131:Respiratory Insufficiency / Q000209:etiology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin